Evidence map›Paper›PMID 41439856›Full record

ArticleAdvances in respiratory medicine2025

Cryptic Circulation and Co-Infections of Endemic Human Coronaviruses During the First Years of the COVID-19 Pandemic in Brazil.

Ana Karolina Mendes Moreno, Rajiv Gandhi Gopalsamy, Lucas Alves da Mota Santana, Marina Dos Santos Barreto, Pedro Henrique Macedo Moura, Deise Maria Rego Rodrigues Silva, Túlio César Rodrigues Leite, Camila de Paula Dias, Breno de Melo Silva, Lysandro Pinto Borges and 1 more

Abstract read
In one paragraph

Article in Advances in respiratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana Karolina Mendes MorenoInstitute of Biological Sciences, Federal University of Goiás, Goiânia 74690-900, Goiás, Brazil.ORCID 0000-0001-9934-3019
Rajiv Gandhi GopalsamyDivision of Phytochemistry and Drug-Design, Department of Biosciences, Rajagiri College of Social Sciences (Autonomous), Kochi 683104, Kerala, India.ORCID 0000-0003-4030-0879
Lucas Alves da Mota SantanaDepartment of Dentistry, Federal University of Sergipe, Aracaju 49060-108, Sergipe, Brazil.
Marina Dos Santos BarretoPostgraduate Program of Pharmaceutical Sciences (PPGCF), Federal University of Sergipe, São Cristóvão 49010-000, Sergipe, Brazil.ORCID 0000-0003-4724-0688
Pedro Henrique Macedo MouraPostgraduate Program of Pharmaceutical Sciences (PPGCF), Federal University of Sergipe, São Cristóvão 49010-000, Sergipe, Brazil.
Deise Maria Rego Rodrigues SilvaPostgraduate Program of Pharmaceutical Sciences (PPGCF), Federal University of Sergipe, São Cristóvão 49010-000, Sergipe, Brazil.ORCID 0000-0001-8916-5271
Túlio César Rodrigues LeiteLaboratory of Biology and Technology of Microorganisms, Department of Biological Sciences, Federal University of Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil.
Camila de Paula DiasLaboratory of Biology and Technology of Microorganisms, Department of Biological Sciences, Federal University of Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil.
Breno de Melo SilvaLaboratory of Biology and Technology of Microorganisms, Department of Biological Sciences, Federal University of Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil.ORCID 0000-0003-2472-8111
Lysandro Pinto BorgesPostgraduate Program of Pharmaceutical Sciences (PPGCF), Federal University of Sergipe, São Cristóvão 49010-000, Sergipe, Brazil.ORCID 0000-0002-1721-1547
Ricardo Lemes GonçalvesLaboratory of Biology and Technology of Microorganisms, Department of Biological Sciences, Federal University of Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil.ORCID 0000-0002-3498-965X

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

During the COVID-19 pandemic, the global focus on SARS-CoV-2 overshadowed the epidemiology of other respiratory pathogens. This study aimed to characterize the circulation of endemic human coronaviruses (HCoVs) in Brazil. We retrospectively analyzed results from 22,472 PCR tests for HCoVs (from 5183 patients) and 601,278 tests for SARS-CoV-2 (from 475,856 patients) between November 2019 and June 2021. HCoVs were detected in 160 patients (3.09%), with HCoV-NL63 as the most frequent species. HCoV circulation was intermittent, with positivity peaks up to 4% but also periods of up to six months with an absence of detections in 2020, contrasting with the sustained high positivity of SARS-CoV-2 (22.37%). Co-infections were frequent: 26.25% of HCoV-positive patients were co-infected with at least one other respiratory pathogen, most commonly Rhinovirus/Enterovirus, and cases involving up to five pathogens were observed, seven patients had co-infections between HCoVs and SARS-CoV-2. These findings reveal the persistent, often cryptic, circulation of HCoVs during the pandemic and highlight their role as key components in complex multi-pathogen infections. This underscores the critical importance of implementing comprehensive molecular diagnostic panels in routine respiratory surveillance to ensure accurate etiology, guide appropriate clinical management, and fully assess the public health burden of non-SARS-CoV-2 coronaviruses.

Indexed as

CoinfectionCoronavirusCOVID-19AdolescentAdultAgedBrazilChildFemaleHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2co-infectionepidemiologyhuman coronaviruses (HCoV)SARS-CoV-2viral surveillance

Identifiers

PMID41439856
PMCPMC12729442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.